Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01BQJ
|
||||
| Former ID |
DIB012055
|
||||
| Drug Name |
TCV-295
|
||||
| Synonyms |
2-(6-Bromo-7-chloro-2,2-dimethyl-2H-1,3-benzoxazin-4-yl)pyridine N-oxide
|
||||
| Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Terminated | [545250] | ||
| CAS Number |
CAS 142304-17-4
|
||||
| Target and Pathway | |||||
| Target(s) | Potassium channel | Target Info | Opener | [531635], [533790] | |
| References | |||||
| Ref 531635 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | ||||
| Ref 533790 | Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs. J Cardiovasc Pharmacol. 1994 Dec;24(6):929-36. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.